Saniona: Receives its Second Orphan Drug Designation - Redeye

Redeye argues that the orphan drug designation is another progress and milestone for the company. It is also a testament to the active work Saniona conducts in the rare eating disorders space.

https://www.redeye.se/research/817736/saniona-receives-its-second-orphan-drug-designation-odd?utm_source=finwire&utm_medium=RSS